These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6949543)

  • 41. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis.
    Lomeo RM; Cornella RJ; Schabel SI; Silver RM
    Am J Med; 1989 Nov; 87(5):525-7. PubMed ID: 2683765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Round fingerpad sign: an early sign of scleroderma.
    Mizutani H; Mizutani T; Okada H; Kupper TS; Shimizu M
    J Am Acad Dermatol; 1991 Jan; 24(1):67-9. PubMed ID: 1999533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive systemic sclerosis sine scleroderma in a child presenting as nocturnal seizures and Raynaud's phenomenon.
    Navon P; Halevi A; Brand A; Branski D; Rubinow A
    Acta Paediatr; 1993 Jan; 82(1):122-3. PubMed ID: 8453211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.
    Arthritis Rheum; 1980 May; 23(5):581-90. PubMed ID: 7378088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diverticular fecalith in scleroderma simulating colonic neoplasm: report of a case.
    Laufer I; Clancy RL; Cockshott WP
    Dis Colon Rectum; 1975; 18(5):403-6. PubMed ID: 1149584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Primary biliary cirrhosis associated with CRST syndrome (calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia). Effect of cytostatic therapy in a case of our observation].
    Amoroso A; Di Rosa R; Afeltra A; Bolognesi A; Ferri GM; Bonomo L
    Recenti Prog Med; 1988 Apr; 79(4):169-72. PubMed ID: 3393727
    [No Abstract]   [Full Text] [Related]  

  • 49. [Serial computed thermography for Raynaud's phenomenon of patient with progressive systemic sclerosis (PSS)].
    Tomono N; Kuriyama T; Mori M; Takahashi Y; Mitsuda T; Aihara Y; Yokota S
    Ryumachi; 1996 Jun; 36(3):522-7. PubMed ID: 8779789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Raynaud's syndrome--main symptom of progressive systemic sclerosis (sclerodermia)].
    Krull P; Alexander K; Fabel H; Ostertag H; Wagner HH; Deicher H
    Med Klin; 1972 Mar; 67(10):332-7. PubMed ID: 5022240
    [No Abstract]   [Full Text] [Related]  

  • 51. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).
    Follansbee WP; Miller TR; Curtiss EI; Orie JE; Bernstein RL; Kiernan JM; Medsger TA
    J Rheumatol; 1990 May; 17(5):656-62. PubMed ID: 2359076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
    Kallenberg CG; Pastoor GW; Wouda AA; The TH
    Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The CREST syndrome. Apropos of a case].
    Nogueira J; Sayago M; Márquez JL; Caballero J; Muñoz E; Trujillo L; de la Santa J
    Rev Esp Enferm Apar Dig; 1986 Oct; 70(4):355-9. PubMed ID: 3786917
    [No Abstract]   [Full Text] [Related]  

  • 54. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma.
    Drosos AA; Pennec YL; Elisaf M; Lamour A; Acritidis NC; Jouquan JR; Moutsopoulos HM; Youinou P
    J Rheumatol; 1991 Nov; 18(11):1685-8. PubMed ID: 1787489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic.
    Melchor S; Joven BE; Andreu JL; Loza E; Garcia de Yebenes MJ; Carmona L; Carreira PE
    Semin Arthritis Rheum; 2016 Dec; 46(3):350-355. PubMed ID: 27373498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autonomic neuropathy in systemic sclerosis.
    Klimiuk PS; Taylor L; Baker RD; Jayson MI
    Ann Rheum Dis; 1988 Jul; 47(7):542-5. PubMed ID: 3401050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration.
    Furst DE; Clements PJ; Saab M; Sterz MG; Paulus HE
    Ann Rheum Dis; 1984 Dec; 43(6):794-801. PubMed ID: 6335385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.